About Somnial

Develops non-invasive bioelectronic devices that use proprietary Temporal Interference nerve stimulation to open airways during sleep, providing an alternative treatment for obstructive sleep apnea (OSA). This technology eliminates the need for masks or surgery, improving comfort and adherence while restoring restful sleep.

```xml <problem> Obstructive sleep apnea (OSA) is commonly treated with devices like CPAP machines or surgical interventions, which can be uncomfortable, invasive, and lead to poor patient compliance. These traditional methods often require wearing a mask during sleep or undergoing surgery, presenting significant barriers to consistent and effective treatment. </problem> <solution> Somnial offers a non-invasive bioelectronic device that utilizes Temporal Interference (TI) nerve stimulation to address OSA. This technology stimulates the appropriate nerves to open airways during sleep, providing an alternative to traditional treatments. By eliminating the need for masks or surgery, Somnial aims to improve patient comfort and adherence, leading to more restful and restorative sleep. The device is designed to be easy to use and integrate into a patient's nighttime routine, offering a convenient and effective solution for managing OSA. </solution> <features> - Non-invasive bioelectronic device using Temporal Interference (TI) nerve stimulation - Targeted nerve stimulation to open airways during sleep - Mask-free and surgery-free treatment option for OSA - Designed for improved patient comfort and adherence - Easy integration into nighttime routine </features> <target_audience> The primary target audience includes individuals diagnosed with obstructive sleep apnea (OSA) seeking a comfortable and non-invasive alternative to traditional treatments like CPAP machines or surgery. </target_audience> ```

What does Somnial do?

Where is Somnial located?

Somnial is based in East New York, United States.

When was Somnial founded?

Somnial was founded in 2022.

Who founded Somnial?

Somnial was founded by Malin Silverå Ejneby.

Malin Silverå Ejneby - CEO

Location

East New York, United States

Founded

2022

Employees

3 employees

Looking for specific startups?

Try our free semantic startup search

Somnial

Score: 18/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

somnialbio.com 100+

Founded 2022 – East New York, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Wyle Solomon

Malin Silverå Ejneby

CEO

Company Description

Problem

Obstructive sleep apnea (OSA) is commonly treated with devices like CPAP machines or surgical interventions, which can be uncomfortable, invasive, and lead to poor patient compliance. These traditional methods often require wearing a mask during sleep or undergoing surgery, presenting significant barriers to consistent and effective treatment.

Solution

Somnial offers a non-invasive bioelectronic device that utilizes Temporal Interference (TI) nerve stimulation to address OSA. This technology stimulates the appropriate nerves to open airways during sleep, providing an alternative to traditional treatments. By eliminating the need for masks or surgery, Somnial aims to improve patient comfort and adherence, leading to more restful and restorative sleep. The device is designed to be easy to use and integrate into a patient's nighttime routine, offering a convenient and effective solution for managing OSA.

Features

Non-invasive bioelectronic device using Temporal Interference (TI) nerve stimulation

Targeted nerve stimulation to open airways during sleep

Mask-free and surgery-free treatment option for OSA

Designed for improved patient comfort and adherence

Easy integration into nighttime routine

Target Audience

The primary target audience includes individuals diagnosed with obstructive sleep apnea (OSA) seeking a comfortable and non-invasive alternative to traditional treatments like CPAP machines or surgery.